CIK 0001853816 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Dermata Therapeutics, Inc.
Sign in to watch- Ticker
- DRMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (858)-223-0882
- Business address
- 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO, CA, 92130
- Former names
- Dermata Therapeutics, Inc.
- 4 Grant or award Director acquired 8,874 shares (grant or award)
- 4 Grant or award Director acquired 8,602 shares (grant or award)
- 4 Grant or award Director acquired 26,441 shares (grant or award)
- 4 Grant or award Director acquired 9,960 shares (grant or award)
- 4 Grant or award Director acquired 18,110 shares (grant or award)
- 4 Grant or award Director acquired 8,602 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 424B3 Offering Prospectus
- 8-K Event Executive or director change
- 8-K Event Delisting notice
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 424B3 Offering Prospectus
- 8-K Event Other events
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- 424B4 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 14 of 19 · 373 filings